Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Erfindergemeinschaft UroPep GbR v. Eli Lilly and Company et al, No. 2:15-cv-01202 (E.D. Tex. May 13, 2016)

Denied
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:15-cv-01202, Dkt. No. 102
Decided
May 13, 2016
Judge
William C. Bryson, J.
Document
Memorandum Opinion and Order
Length
15 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is the motion of defendant Eli Lilly & Co. (“Lilly”) for a protective order. Dkt. No. 88. The motion is DENIED. A. Background In the course of discovery in this case, th e plaintiff, Erfindergemeinschaft UroPep GbR (“UroPep”) served Lilly with a set of 18 interrogatories. Pursuant to Rule 26(c), Fed. R. Civ. P., Lilly has moved the Court for a protective order striking UroPep’s interrogatories and requiring UroPep to serve new interrogatories in compliance with Rule 33, Fed. R. Civ. P., and the Court’s Discovery Order in this case, Dkt.